PACIOTTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.205
EU - Europa 1.103
AS - Asia 484
SA - Sud America 74
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.874
Nazione #
US - Stati Uniti d'America 1.199
IT - Italia 296
IE - Irlanda 244
SG - Singapore 190
HK - Hong Kong 119
RU - Federazione Russa 115
FR - Francia 110
CN - Cina 80
UA - Ucraina 76
BR - Brasile 67
VN - Vietnam 67
DE - Germania 52
RO - Romania 49
SE - Svezia 44
FI - Finlandia 38
GB - Regno Unito 17
BE - Belgio 16
TR - Turchia 12
NL - Olanda 9
AT - Austria 8
CH - Svizzera 7
GR - Grecia 7
CZ - Repubblica Ceca 5
JP - Giappone 3
KR - Corea 3
MX - Messico 3
PL - Polonia 3
ZA - Sudafrica 3
AM - Armenia 2
CA - Canada 2
CY - Cipro 2
EC - Ecuador 2
ES - Italia 2
PY - Paraguay 2
UZ - Uzbekistan 2
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
EG - Egitto 1
EU - Europa 1
HN - Honduras 1
IN - India 1
KE - Kenya 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 2.874
Città #
Chandler 268
Dublin 244
Perugia 173
Singapore 146
Hong Kong 119
San Mateo 104
Ann Arbor 68
Dong Ket 67
Altamura 59
Boardman 59
Beijing 54
Santa Clara 51
Bucharest 49
Wilmington 46
Medford 44
Princeton 44
Jacksonville 38
Lawrence 38
Moscow 35
Ashburn 29
Andover 26
Des Moines 24
Redmond 21
Brussels 15
Helsinki 15
Saint Petersburg 13
Los Angeles 11
Nuremberg 10
Redwood City 10
Norwalk 8
Houston 7
Izmir 7
San Paolo di Civitate 7
Seattle 6
Woodbridge 6
Dallas 5
Fairfield 5
Falls Church 5
Milan 5
The Dalles 5
Chicago 4
Florence 4
São Paulo 4
Amsterdam 3
Belo Horizonte 3
Cambridge 3
Curitiba 3
Den Haag 3
Falkenstein 3
Frankfurt am Main 3
Rome 3
Seoul 3
Tokyo 3
Vienna 3
Assisi 2
Brno 2
Guarulhos 2
Johannesburg 2
Lappeenranta 2
Lausanne 2
London 2
Mexico City 2
Nicosia 2
Olomouc 2
Ottawa 2
Spoleto 2
Uberlândia 2
Vicenza 2
Yerevan 2
Aguaí 1
Aksaray 1
Ankara 1
Aracaju 1
Arara 1
Asunción 1
Athens 1
Bacabal 1
Barreiros 1
Bauru 1
Bergen 1
Bologna 1
Brumado 1
Buenos Aires 1
Cairo 1
Caçapava 1
Changsha 1
Cotia 1
Council Bluffs 1
Cruz Alta 1
Dushanbe 1
Erechim 1
Ergolding 1
Esslingen am Neckar 1
Frankfurt Am Main 1
Goiânia 1
Guanambi 1
Guangzhou 1
Guarapari 1
Guayaquil 1
Gunzenhausen 1
Totale 2.052
Nome #
CSF and blood biomarkers for Parkinson's disease 134
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 119
Accumulation of free oligosaccharides and tissue damage in cytosolic alpha-mannosidase (Man2c1)-deficient mice. 103
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 97
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 94
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 83
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 82
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 80
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 78
di-N-acetylchitobiase-deficient mice accumulate Man2GlcNAc2 and Man3GlcNAc2 77
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 76
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 75
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 75
Lysosomal alpha-mannosidase and alpha-mannosidosis 74
Identification of two novel beta-mannosidosis-associated sequence variants: biochemical analysis of beta mannosidase (MANBA) missense mutations. 70
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 70
First pilot newborn screening for our lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene 69
Lysosomal enzymes in Parkinson's disease 69
Generation of a chitobiase knock out mouse model 68
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 67
Free oligosaccharides accumulation and tissue damages in Ma2c1 deficient mice 66
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 66
Molecular cloning and structural organization of the gene encoding the mouse lysosomal di-N-acetylchitobiase (ctbs) 64
Lysosomal di-N-acetylchitobiase-deficient mouse tissues accumulate Man2GlcNAc2 and Man3GlcNAc2 62
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 60
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 59
Biochemical analysis of missense mutations in beta-mannosidosis 57
Novel CSF biomarkers to discriminate FTLD and its pathological subtypes 57
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 56
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 56
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 56
Identification and molecular characterization of six novel mutations in the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTG) gene in patients with mucolipidosis III gamma 54
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 53
Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links 53
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 53
Next generation sequencing applications in agro biotechnology 52
Parkinson's and Lewy body dementia CSF biomarkers 50
Origin of α-mannosidase activity in CSF 49
Emerging therapies and therapeutic concepts for lysosomal storage diseases 46
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease 45
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 41
Interlaboratory proficiency processing scheme in CSF aliquoting: Implementation and assessment based on biomarkers of Alzheimer's disease 39
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 38
Lysosomal enzymes in PD: further evidence is needed. 37
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 31
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 27
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 27
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 15
Totale 3.029
Categoria #
all - tutte 13.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020112 0 0 0 0 0 0 0 0 0 46 26 40
2020/2021341 7 18 2 20 99 9 23 11 33 16 21 82
2021/2022504 16 78 7 11 7 19 6 107 37 51 74 91
2022/2023841 51 160 15 74 62 92 0 32 312 1 31 11
2023/2024300 27 26 25 6 2 1 75 14 20 14 46 44
2024/2025552 4 56 29 41 78 50 41 38 160 55 0 0
Totale 3.029